(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Letter Sequence Other |
---|
EPID:L-2022-LLA-0150, International, Submittal of License Amendment Request 9375-1 for the HI-STAR Atb 1T Non-Fuel Waste Transport System (Approved, Closed) EPID:L-2022-LLE-0030, International, Submittal of License Amendment Request 9375-1 for the HI-STAR Atb 1T Non-Fuel Waste Transport System (Approved, Closed) |
|
MONTHYEARML22050A0012022-02-18018 February 2022 International, Submittal of License Amendment Request 9375-1 for the HI-STAR Atb 1T Non-Fuel Waste Transport System Project stage: Request ML22130A7052022-05-10010 May 2022 International - Resubmittal of License Amendment Request 9375-1 for the HI-STAR Atb 1T Non-Fuel Waste Transport System Project stage: Request ML22161A0592022-06-0909 June 2022 International, Modification of License Amendment Request 9375-1 for the HI-STAR Atb 1T Non-Fuel Waste Transport System Project stage: Request ML22161A0582022-06-0909 June 2022 International, Modification of License Amendment Request 9375-1 for the HI-STAR Atb 1T Non-Fuel Waste Transport System Project stage: Request ML22235A1142022-08-25025 August 2022 Letter - Request for Additional Information for the Review of the Atb 1T Package - 2022 Project stage: RAI ML22235A1132022-08-25025 August 2022 RAIs for the Model No. HI-STAR Atb 1T Package Project stage: Request ML22235A1152022-08-25025 August 2022 Enc - 9375 RAI 2022 Project stage: RAI ML22285A1152022-10-0707 October 2022, 12 October 2022 Application for Technical Specification Change and Exemption Request Regarding Use of Framatome Gaia Fuel (LDCN 22-0002) Project stage: Request ML22285A1232022-10-12012 October 2022 Attachment 6 to Enclosure 1: ANP-3944NP, Callaway Realistic Large Break LOCA Analysis with Gaia Fuel Design, Revision 1, Dated October 2022 Project stage: Request ML22285A1252022-10-12012 October 2022 Attachment 8 to Enclosure 1: ANP-3969NP, Callaway Non-LOCA Summary Report, Revision 2, Dated October 2022 Project stage: Request ML22285A1222022-10-12012 October 2022 Attachment 5 to Enclosure 1: ANP-3947NP, Callaway Unit 1 License Amendment Request Inputs for Use of Framatome Fuel, Revision 3, Dated October 2022 Project stage: Request ML22285A1242022-10-12012 October 2022 Attachment 7 to Enclosure 1: ANP-3943NP, Callaway Small Break LOCA Analysis with Gaia Fuel Design, Revision 1, Dated October 2022 Project stage: Request ML22287A1392022-10-14014 October 2022 Responses to HI-STAR Atb 1T Requests for Additional Information Project stage: Other ML22287A1412022-10-14014 October 2022 Attachment 2 - HI-STAR Atb 1T Amendment Request 1 RAI Responses Project stage: Other ML22287A1432022-10-14014 October 2022 Attachment 4 - Safety Analysis Report on the HI-STAR Atb 1T Non-Fuel Waste Transport System Project stage: Other ML22287A1382022-10-14014 October 2022 Responses to HI-STAR Atb 1T Requests for Additional Information Project stage: Request ML22287A1462022-10-14014 October 2022 Affidavit of Kimberly Manzione Project stage: Other ML22305A6042022-11-0101 November 2022 International - Supplemental Information for Responses to HI-STAR Atb 1T Requests for Additional Information Project stage: Supplement ULNRC-06783, Enclosure 2: Affidavit for Withholding2022-11-16016 November 2022 Enclosure 2: Affidavit for Withholding Project stage: Other ML22335A4992022-11-16016 November 2022 Enclosure 1: Responses to Requested Information Project stage: Other ML22335A4972022-11-16016 November 2022, 1 December 2022 Supplement to License Amendment and Exemption Request Regarding Use of Framatome Gaia Fuel (LDCN 22-0002) Project stage: Request ML22335A5012022-11-16016 November 2022 Enclosure 3: ANP-4012NP, Revision 1, Callaway Rod Ejection Accident Analysis Project stage: Other ML22322A0062022-11-17017 November 2022 NRR E-mail Capture - Final - LIC-109 Acceptance Review (Unacceptable for Review with Opportunity to Supplement) Callaway - LAR for Proposed Changes to TS and Exemption Request Use of Framatome Gaia Fuel - L-2022-LLA-0150 & L-2022-LLE-0030 Project stage: Acceptance Review ML22335A4982022-12-0101 December 2022 Supplement to License Amendment and Exemption Request Regarding Use of Framatome Gaia Fuel (LDCN 22-0002) Project stage: Supplement ML22343A2612022-12-0909 December 2022 International - Submittal of Final SAR for HI-STAR ATB-1T Amendment 1 Project stage: Other ML22334A2642022-12-13013 December 2022 Enclosure 2 - Safety Evaluation Report Project stage: Approval ML22334A2612022-12-13013 December 2022 Certificate of Compliance No. 9375, Revision No. 1, for the Model No. HI-STAR ATB1T Package Project stage: Request ML22334A2632022-12-13013 December 2022 Enclosure 1 - Certificate of Compliance Rev. No. 1 Project stage: Other ML22334A2622022-12-13013 December 2022 Cover letter- Certificate of Compliance No. 9375, Revision No. 1, for the Model No. HI-STAR ATB1T Package Project stage: Other ML22348A1162022-12-21021 December 2022 Acceptance of Requested Licensing Actions Application for License Amendment & Regulatory Exemptions for TS Change & Exemption Request Regarding Use of Framatome Gaia Fuel (EPID L-2022-LLA-0150 & EPID L-2022-LLE-0030) Project stage: Acceptance Review ML23068A3772023-03-20020 March 2023 Regulatory Audit Plan and Setup of Online Reference Portal for License Amendment Request and Exemption for Fuel Transition to Framatome Gaia Fuel (EPID L-2022-LLA-0150 and EPID L-2022-LLE-0030) - Nonproprietary Project stage: Other ML23107A1812023-04-17017 April 2023 NRR E-mail Capture - Regulatory Audit Questions - Callaway LAR and Exemption for Fuel Transition to Framatome Gaia Fuel - EPIDs - L-2022-LLA-0150 and L-2022-LLE-0030 Project stage: Approval ML23114A2302023-04-24024 April 2023 NRR E-mail Capture - Regulatory Audit Question - Callaway LAR and Exemption for Fuel Transition to Framatome Gaia Fuel - EPIDs - L-2022-LLA-0150 and L-2022-LLE-0030 Project stage: Approval ULNRC-06808, Affidavit2023-04-27027 April 2023 Affidavit Project stage: Other ML23129A7932023-04-27027 April 2023, 9 May 2023 Post-Audit Supplement to License Amendment Request and Exemption to Allow Use of Framatome Gaia Fuel (LDCN 22-0002) (Iepid L-2022-LLA-0150 and EPID L-2022-LLE-0030) Project stage: Request ML23118A3492023-05-0808 May 2023 Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML23129A7972023-05-0909 May 2023 Response to Audit Questions Project stage: Other ML23129A7942023-05-0909 May 2023 Post-Audit Supplement to License Amendment Request and Exemption to Allow Use of Framatome Gaia Fuel (LDCN 22-0002) (Iepid L-2022-LLA-0150 and EPID L-2022-LLE-0030) Project stage: Supplement ULNRC-06821, Post-Audit Follow-Up Information in Support of Callaway'S License Amendment Request and Proposed Exemption to Allow Use of Framatome Gaia Fuel (LDCN 22-0002) (EPID L-2022-LLA-0150 and EPID L-2022-LLE-00301)2023-06-21021 June 2023 Post-Audit Follow-Up Information in Support of Callaway'S License Amendment Request and Proposed Exemption to Allow Use of Framatome Gaia Fuel (LDCN 22-0002) (EPID L-2022-LLA-0150 and EPID L-2022-LLE-00301) Project stage: Request ML23215A1972023-08-0303 August 2023 Supplement to License Amendment and Exemption Request Regarding Use of Framatome Gaia Fuel (LDCN 22-0002) Project stage: Supplement ML23215A1962023-08-0303 August 2023, 31 August 2023 Supplement to License Amendment and Exemption Request Regarding Use of Framatome Gaia Fuel (LDCN 22-0002) Project stage: Request ML23219A1392023-08-15015 August 2023 Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML23215A1992023-08-31031 August 2023 ANP-4012NP, Callaway, Unit 1, Rod Ejection Accident Analysis Revision 2, August 2023 Project stage: Request ML23206A1992023-09-15015 September 2023 Regulatory Audit Summary Regarding License Amendment and Regulatory Exemptions Request for Fuel Transition to Framatome Gaia Fuel (Epids L-2022-LLA-0150 and L-2022-LLE-0030) Project stage: Other ML23240A3692023-10-0505 October 2023 Issuance of Amendment No. 235 to Revise Technical Specifications to Use of Framatome Gaia Fuel (EPID L-2022-LLA-0150) (Non-Proprietary) Project stage: Approval ML23234A1522023-10-0505 October 2023 Exemption from the Requirements of 10 CFR Part 50, Section 50.46, and Appendix K Regarding Use of M5 Cladding Material (EPID L-2022-LLE-0030) (Letter) Project stage: Approval ML23234A1532023-10-0505 October 2023 Exemption from the Requirements of 10 CFR Part 50, Section 50.46, and Appendix K Regarding Use of M5 Cladding Material (EPID L-2022-LLE-0030) (Exemption) Project stage: Approval ML23234A1542023-10-11011 October 2023 Exemption from the Requirements of 10 CFR Part 50, Section 50.46, and Appendix K Regarding Use of M5 Cladding Material (EPID L-2022-LLE-0030) (FRN) Project stage: Approval 2022-08-25
[Table View] |
|
---|
Category:Legal-Affidavit
MONTHYEARULNRC-06829, Affidavit2023-08-0303 August 2023 Affidavit ULNRC-06808, Affidavit2023-04-27027 April 2023 Affidavit ULNRC-06796, Enclosure 6 - Affidavit for Withholding by Kimberly Manzione2023-02-14014 February 2023 Enclosure 6 - Affidavit for Withholding by Kimberly Manzione ULNRC-06783, Enclosure 2: Affidavit for Withholding2022-11-16016 November 2022 Enclosure 2: Affidavit for Withholding ULNRC-06774, Affidavits for Withholding2022-10-26026 October 2022 Affidavits for Withholding ULNRC-06768, Attachment 4 to Enclosure 1: Framatome Affidavits for Withholding from Public Disclosure2022-10-0707 October 2022 Attachment 4 to Enclosure 1: Framatome Affidavits for Withholding from Public Disclosure ULNRC-06723, Attachment 4 to Enclosure 1 - Holtec Affidavit for Withholding2022-06-30030 June 2022 Attachment 4 to Enclosure 1 - Holtec Affidavit for Withholding ULNRC-06729, Attachment 4 - Framatome Affidavits for Withholding2022-06-0202 June 2022 Attachment 4 - Framatome Affidavits for Withholding ULNRC-06716, Presentation Information for Third Pre-Application Meeting Regarding Use of Framatome Fuel - Affidavit2022-02-11011 February 2022 Presentation Information for Third Pre-Application Meeting Regarding Use of Framatome Fuel - Affidavit ULNRC-06695, Affidavit of Morris Byram, Framatome, Inc2021-09-30030 September 2021 Affidavit of Morris Byram, Framatome, Inc ULNRC-06694, Framatome, Inc - Affidavit for Morris Byram2021-09-24024 September 2021 Framatome, Inc - Affidavit for Morris Byram ULNRC-06654, Affidavit for Morris Byram2021-05-0303 May 2021 Affidavit for Morris Byram ULNRC-06603, Corrected Affidavit for Proprietary Information Provided in Support of License Amendment Request Regarding Defferal of Upcoming Steam Generator Inspection (LDCN 20-001)2020-09-0303 September 2020 Corrected Affidavit for Proprietary Information Provided in Support of License Amendment Request Regarding Defferal of Upcoming Steam Generator Inspection (LDCN 20-001) ULNRC-06595, Response to Request for Additional Information Regarding License Amendment Request for Deferral of Upcoming Steam Generator Inspection (LDCN 20-0013))2020-08-25025 August 2020 Response to Request for Additional Information Regarding License Amendment Request for Deferral of Upcoming Steam Generator Inspection (LDCN 20-0013)) ULNRC-06586, Attachment 4 - Affidavit2020-06-24024 June 2020 Attachment 4 - Affidavit ML14093A7752014-03-28028 March 2014 Attachment 3: Westinghouse Application for Withholding Proprietary Information from Public Disclosure CAW-14-3933, Accompanying Affidavit, Proprietary Information Notice, and Copyright Notice ULNRC-06108, Attachment 3: Westinghouse Application for Withholding Proprietary Information from Public Disclosure CAW-14-3933, Accompanying Affidavit, Proprietary Information Notice, and Copyright Notice2014-03-28028 March 2014 Attachment 3: Westinghouse Application for Withholding Proprietary Information from Public Disclosure CAW-14-3933, Accompanying Affidavit, Proprietary Information Notice, and Copyright Notice ML12298A0302012-10-22022 October 2012 Transmittal of Pci Proprietary Document No. PCI-2012.10.22-1 Rev 0; Responses to Staff Comments Dated July 11, 2012 2023-08-03
[Table view] |
Text
Enclosure 2 to ULNRC-06808 Page 1 of 4 ENCLOSURE 2 AFFIDAVIT FOR WITHHOLDING The enclosed affidavit is provided by Framatome, Inc. that sets forth the basis on which the proprietary information in Enclosure 1 may be withheld from public disclosure by the Commission and addresses with specificity the considerations listed in 10 CFR 2.390(b)(4). Correspondence with respect to the proprietary aspects of Enclosure 1 or the supporting affidavit should be addressed to Morris Byram of Framatome Inc.
3 pages follow this cover sheet.
AFFIDAVIT
- 1. My name is Morris Byram. I am Manager, Licensing & Regulatory Affairs for Framatome Inc. (Framatome) and as such I am authorized to execute this Affidavit.
- 2. I am familiar with the criteria applied by Framatome to determine whether certain Framatome information is proprietary. I am familiar with the policies established by Framatome to ensure the proper application of these criteria.
- 3. I am familiar with the Framatome information contained in enclosure 1 to Ameren letter number ULNRC-06808 and referred to herein as Document. Information contained in this Document has been classified by Framatome as proprietary in accordance with the policies established by Framatome for the control and protection of proprietary and confidential information.
- 4. This Document contains information of a proprietary and confidential nature and is of the type customarily held in confidence by Framatome and not made available to the public. Based on my experience, I am aware that other companies regard information of the kind contained in this Document as proprietary and confidential.
- 5. This Document has been made available to the U.S. Nuclear Regulatory Commission in confidence with the request that the information contained in this Document be withheld from public disclosure. The request for withholding of proprietary information is made in accordance with 10 CFR 2.390. The information for which withholding from disclosure is requested qualifies under 10 CFR 2.390(a)(4) Trade secrets and commercial or financial information.
- 6. The following criteria are customarily applied by Framatome to determine whether information should be classified as proprietary:
(a) The information reveals details of Framatomes research and development plans and programs or their results.
(b) Use of the information by a competitor would permit the competitor to significantly reduce its expenditures, in time or resources, to design, produce, or market a similar product or service.
(c) The information includes test data or analytical techniques concerning a process, methodology, or component, the application of which results in a competitive advantage for Framatome.
(d) The information reveals certain distinguishing aspects of a process, methodology, or component, the exclusive use of which provides a competitive advantage for Framatome in product optimization or marketability.
(e) The information is vital to a competitive advantage held by Framatome, would be helpful to competitors to Framatome, and would likely cause substantial harm to the competitive position of Framatome.
The information in this Document is considered proprietary for the reasons set forth in paragraph 6(c) and 6(d) above.
- 7. In accordance with Framatomes policies governing the protection and control of information, proprietary information contained in this Document has been made available, on a limited basis, to others outside Framatome only as required and under suitable agreement providing for nondisclosure and limited use of the information.
- 8. Framatome policy requires that proprietary information be kept in a secured file or area and distributed on a need-to-know basis.
- 9. The foregoing statements are true and correct to the best of my knowledge, information, and belief.
I declare under penalty of perjury that the foregoing is true and correct.
Executed on: (4/27/2023)
Digitally signed by BYRAM Morris BYRAM Morris Date: 2023.04.27 10:27:07
-07'00' (NAME) morris.byram@framatome.com